RANZCR provided written feedback to the Medical Services Advisory Committee (MSAC) to support MSAC Application 1638 – Proton Beam Therapy for paediatric and rare cancers.

RANZCR advocates strongly for a nationally coordinated approach in the delivery of PBT to ensure sustainable and affordable access to the highest quality care and research efforts, alongside fair and equitable access to PBT for the wider patient population across Australia.